[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573605":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":40,"centralContacts":45,"locations":51,"responsibleParty":65,"collaborators":67,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":21,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":21,"maxAge":21,"enrollmentInfo":79,"targetDuration":21,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":53,"whyStopped":21,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"University of Copenhagen","OTHER",[8,17],{"label":9,"type":10,"description":11,"interventionNames":12},"Cluster package intervention group","EXPERIMENTAL","The intervention consists of:\n\n* A pre-recorded podcast to be heard by the GP's prior to the cluster meeting.\n* A two-hour meeting with a specific slideshow about PSA, data from the clinics within the cluster, current guidelines, cases and group discussions.\n* Two sets of hand-outs for the GP's to use in their own clinics.\n\nThe intervention group will be offered the intervention during the intervention period of six months.",[13,14,15,16],"Behavioral: Podcast","Behavioral: Cluster meeting","Behavioral: Hand-out material 1","Behavioral: Hand-out material 2",{"label":18,"type":19,"description":20,"interventionNames":21},"Standard care control group","NO_INTERVENTION","The control group will be offered the intervention at the end of the intervention period.",null,[23,28,32,36],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":21},"BEHAVIORAL","Podcast","A pre-recorded podcast with a urologist and a GP discussing the theme to promote preparatory reflections among the GPs before the cluster meeting",[9],{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":21},"Cluster meeting","A two-hour meeting facilitated by either the GPs cluster coordinator, another GP from the cluster or a facilitator outside the cluster chosen by the cluster itself with specific slides about PSA in general, guidelines, expert videos, data from the clinics, cases, and group discussions",[9],{"type":24,"name":33,"description":34,"armGroupLabels":35,"otherNames":21},"Hand-out material 1","Hand-outs of the main take-home messages to facilitate further discussion in their respective GP offices",[9],{"type":24,"name":37,"description":38,"armGroupLabels":39,"otherNames":21},"Hand-out material 2","Hand-outs to be used by GP and patients to facilitate communication about the relevance of taking a PSA-test",[9],[41],{"name":42,"affiliation":43,"role":44},"Marius Brostrøm Kousgaard, Associate professor","Center of General Practice, Department of Public Health, University of Copenhagen","PRINCIPAL_INVESTIGATOR",[46],{"name":47,"role":48,"phone":49,"phoneExt":21,"email":50},"Christian Leick, PhD student","CONTACT","004560898397","christian.leick@sund.ku.dk",[52],{"facility":43,"status":53,"city":54,"state":21,"zip":21,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"RECRUITING","Copenhagen","Denmark","DK",{"type":58,"coordinates":59},"Point",[60,61],12.56553,55.67594,{"lat":61,"lon":60},[64],{"name":47,"role":48,"phone":49,"phoneExt":21,"email":50},{"type":66,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR",[68],{"name":69,"class":70},"Kvalitet i Almen Praksis (KiAP)","UNKNOWN","100573605","a-cluster-package-intervention-to-promote-an-evidence-based-use-of-psa-tests-in-general-practice-100573605",false,"NCT06748456","A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice","Development and Evaluation of a Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice: A Cluster Randomized Trial","Inclusion Criteria:\n\n* Quality clusters with a cluster coordinator\n* Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025.\n\nExclusion Criteria:\n\n* Quality clusters who already planned their cluster meetings in 2025.\n* Quality clusters unwilling to await allocation before planning their cluster meetings in 2025.\n* Quality clusters participating in the pilot study","ALL",{"count":80,"type":81},50,"ESTIMATED","INTERVENTIONAL",[84],"NA","It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test.\n\nThe aim of this cluster randomized trial is to evaluate the effectiveness of a complex intervention aimed at improving the use of evidence based practice when using prostate specific antigen tests in general practice.\n\nThe complex intervention in this study is a so called cluster package which is meeting material to a quality cluster meeting as almost every general practitioner is a member of a quality cluster. Therefore, the investigators have developed a cluster package aimed at promoting an evidence-based use of the prostate specific antigen test to general practitioners.",[87,88,89],"Prostate Cancer","Evidence Based Medicine","Prostate Specific Antigen",[91,87,92,93,94],"PSA-test","Evidence based medicine","Quality clusters","General practice","2024-12-20",{"date":97,"type":98},"2024-12-27","ACTUAL",{"date":100,"type":98},"2024-09-09",{"date":102,"type":81},"2026-01-01",{"name":5,"class":6},1]